Abstract:Parkinson's disease (PD) is the second most common neurodegenerative disease, posing a significant threat to an individual's health, particularly among the elderly. An incomplete understanding of the pathogenesis underlying PD renders the single therapeutic model ineffective. Oxidative stress and abnormal alpha-synuclein (alpha-Syn) aggregation are two crucial factors accounting for dopaminergic neuron loss. Therefore, combined PD therapy that inhibits and reduces alpha-Syn aggregation and regulates the balance of reactive oxygen species (ROS) holds promise. In this study a novel nanodrug, polydopamine-based curcumin-loaded nanoparticles (PC NPs), based on polydopamine (PDA)-assembled curcumin (Cur) nanoparticles was designed, which was then modified with a peptide obtained from rabies virus glycoprotein (RVG) 29 (obtained RPC NPs) to target the brain. Cur and PDA of ROS-responsive nanoparticles (RPC NPs) significantly scavenged a broad spectrum of ROS. Cur inhibited and removed alpha-Syn aggregation, thus protecting PC12 cells from rotenone-induced cell death. RPC NPs were also shown to prolong the lifespan of Caenorhabditis elegans and restored dopamine-dependent behaviors, including area-restricted searching, ethanol avoidance, and the basal slowing response, by using 6-hydroxydopamine (6-OHDA)-pretreated C. elegans wild-type Bristol (N2) and the nematode transgenic hus111 strain as models. In vivo animal studies showed that RPC NPs significantly lowered dopaminergic neuron damage and improved the neurobehavioral abnormalities in PD mice, while having no noticeable systemic side effects. RPC NPs also decreased alpha-Syn accumulation and reduced oxidative stress in the striatum and substantia nigra. This multi-functional synergetic strategy may provide a new candidate for highly efficient combination therapy in patients with PD.

Selenium nanoparticles decorated with polysaccharides from Sargassum fusiforme protects against 6-OHDA-induced neurotoxicity in PC12 cells and rat model of Parkinson's disease

Selenium Nanoparticles as Neuroprotective Agents: Insights into Molecular Mechanisms for Parkinson's Disease Treatment

Bio-synthesized selenium nanoparticles ameliorate Brain oxidative stress in Parkinson disease rat models

Integrated Insight into the Molecular Mechanisms of Selenium-Modulated, MPP+-induced Cytotoxicity in a Parkinson’s Disease Model

Integrated insight into the molecular mechanisms of selenium-modulated, MPP + -induced cytotoxicity in a Parkinson's disease model

P1‐028: Protective Effects of Hydrogen Sulfide on Neurodegeneration in Unilateral 6‐ohda‐lesioned Rats

Polydopamine-Based Nanocomposite As a Biomimetic Antioxidant with a Variety of Enzymatic Activities for Parkinson's Disease.

Engineered Selenium/Human Serum Albumin Nanoparticles for Efficient Targeted Treatment of Parkinson's Disease via Oral Gavage

Neuroprotective Effects of Hydrogen Sulfide on Parkinson'S Disease Rat Models

Sulforaphane protects against rotenone-induced neurotoxicity in vivo : Involvement of the mTOR, Nrf2 and autophagy pathways

P1‐029: Protective Effect of Hydrogen Sulfide Against 6‐ohda‐induced Cell Injury in SH‐SY5Y Cells Involves PKC/PI3K/Akt Pathway

Boosting Neurite Outgrowth and Anti-Oxidative Stress for Treatment of Parkinson's Disease by Biomimetic Ultrasmall Nanoparticles

Neuroprotective effect of salidroside against 6-OHDA-induced oxidative stress in PC12 cells

Hydrogen sulphide attenuates neuronal apoptosis of substantia nigra by re-establishing autophagic flux via promoting leptin signalling in a 6-hydroxydopamine rat model of Parkinson's disease

Sulfuretin inhibits 6-hydroxydopamine-induced neuronal cell death via reactive oxygen species-dependent mechanisms in human neuroblastoma SH-SY5Y cells

Stimulus-responsive curcumin-based polydopamine nanoparticles for targeting Parkinson?s disease by modulating ?-synuclein aggregation and reactive oxygen species

Synthesis of ROS Scavenging Microspheres from a Dopamine Containing Poly(β-Amino Ester) for Applications for Neurodegenerative Disorders.

Neuroprotective Effect of Dioscin against Parkinson's Disease via Adjusting Dual-Specificity phosphatase 6(DUSP6)-Mediated Oxidative Stress

Modulating SQSTM1/p62-dependent selective autophagy of neurons by activating Nrf2 with multifunctional nanoparticles to eliminate α-synuclein aggregates and boost therapy of Parkinson’s disease

Modulating SQSTM/p62-dependent selective autophagy of neurons by activating Nrf2 with multifunctional nanoparticles to eliminate -synuclein aggregates and boost therapy of Parkinson's disease

Stimulus-responsive curcumin-based polydopamine nanoparticles for targeting Parkinson's disease by modulating α-synuclein aggregation and reactive oxygen species